热点栏目 自选股 数据中心 行情中心 资金流向 模拟交易

客户端

　　华昊中天医药-B（02563）发布公告，本公司已接获中国证监会就申请于2026年2月5日发出的备案通知书。根据备案通知书，本公司已就实施H股全流通完成向中国证监会备案。备案通知书将自其发出日期起12个月内有效。本公司将向联交所申请转换及上市。

　　于本公告日期，转换及上市的实施计划详情尚未最终确定。本公司将根据上市规则及适用法律的规定于适当时候就转换及上市的进展及详情作出进一步公告。

海量资讯、精准解读，尽在新浪财经APP

责任编辑：卢昱君

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.